THE RIVER THU THIEM
Red Capital invested in The River Thủ Thiêm residential area project in 2020.
Red Capital invested in Imexpharm Pharmaceutical Joint Stock Company (“Imexpharm”) in 2017 when Imexpharm invested in its first EU-GMP manufacturing line. Imexpharm has always been a pioneer in producing high-quality pharmaceuticals by proactively adopting European technology in manufacturing since 1999. Currently, the company boasts the largest number of EU-GMP standard production lines in the country, with 11 EU-GMP lines across 3 factory clusters.
Receive the latest notifications from us.
Red Capital 2023. All rights reserved. Designed by SaoKim Digital